Interventional Cardiology Devices Market by Type (Stents, Structural Heart Devices, Angioplasty Balloons (Drug-Eluting), Angiography Catheters, Plaque Modification Devices (Thrombectomy Devices), Guidewires, Introducer Sheaths) - Global Forecast to 2029

Interventional Cardiology Devices Market by Type (Stents, Structural Heart Devices, Angioplasty Balloons (Drug-Eluting), Angiography Catheters, Plaque Modification Devices (Thrombectomy Devices), Guidewires, Introducer Sheaths) - Global Forecast to 2029

The global interventional cardiology devices market is projected to reach USD 27.80 billion in 2024 and is projected to reach USD 37.27 billion by 2029, at a CAGR of 6.0% during the forecast period.

The growth of the interventional cardiology devices market is driven by several key factors, most notably the increasing prevalence of cardiovascular diseases (CVD) worldwide, advancements in minimally invasive procedures, and growing demand for improved patient outcomes. As rates of heart disease, hypertension, and diabetes rise, the need for effective treatments such as angioplasty, stenting, and valve replacements also increases. Technological innovations, including the development of drug-eluting stents, bioresorbable scaffolds, and advanced imaging technologies, have enabled safer and more precise procedures, which contribute to the market’s growth.

“Based on the angioplasty balloons type, the old/normal balloons segment is expected to grow by the highest CAGR in the interventional cardiology devices market.”

Traditional angioplasty balloons, also known as plain old balloon angioplasty (POBA), offer several advantages over drug-eluting balloons (DEBs) in certain clinical scenarios. First, traditional balloons tend to be less costly than DEBs, making them a more accessible option for healthcare systems and patients, especially in regions with limited healthcare budgets or where reimbursement policies may not fully cover DEB, also POBA also has a simpler mechanism—it dilates narrowed blood vessels by compressing plaque against the vessel walls without releasing drugs, which can be beneficial in cases where the risks associated with drug delivery aren’t justified. For example, in acute settings like treating certain types of arterial blockages where drug-delivery isn’t critical to outcomes, POBA may provide sufficient clinical results without the added complexity or cost of drug elution.

“The embolic protection devices segment in hemodynamic flow alteration devices segment is expected to grow with the highest CAGR in the interventional cardiology devices market.”

Embolic protection devices (EPDs) are a vital advancement in interventional cardiology, designed to capture and remove debris that may dislodge during vascular procedures, thereby minimizing the risk of embolization. These devices are particularly beneficial during interventions like carotid artery stenting, where dislodged particles could travel to the brain and cause strokes. By capturing such debris, EPDs significantly reduce periprocedural stroke risks and improve the safety profile of these interventions.

“The guidewires segment in other devices segment is expected to grow with the highest CAGR in the interventional cardiology devices market.”

Guidewires are essential in interventional cardiology, offering precision, flexibility, and control that enhance the safety and effectiveness of procedures like angioplasty and stent placement. These thin, flexible wires guide catheters through blood vessels, allowing clinicians to navigate complex vascular structures and reach targeted areas with minimal trauma to surrounding tissues. Their superior torque response and maneuverability help cardiologists access difficult-to-reach lesions, improving procedural success rates and reducing the need for open surgery.

“Based on the end user, hospitals segment is expected to grow by the highest CAGR in the interventional cardiology devices market.

Most interventional cardiology procedures, such as angioplasties, stent placements, and structural heart interventions, are carried out in hospitals because they boast special facilities and the sophisticated imaging technologies that would treat a patient with maximum quality. They are well equipped both for simple and complicated processes with a good staff; besides, they are where they can be managed whenever a complication arises. These settings enable cardiologists to take the latest tool systems into practice, including drug-eluting stents, rotational atherectomy and intravascular ultrasound, to ensure utmost precision and safety for patients.

“Asia Pacific to grow with the highest CAGR in the interventional cardiology devices market during the forecast period.”

The Asia-Pacific region is also expected to experience maximum growth in the interventional cardiology devices market in the next few years due to several key factors. Growth is driven by an increasingly aging population, the growing prevalence of cardiovascular diseases, and increased adoption of minimally invasive procedures, especially in countries such as China, Japan, and India. Increased healthcare expenses and development of health infrastructure promote the availability of high-end interventional cardiology services throughout the region.

The break up of the profile of primary participants in the interventional cardiology devices market:

By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%

By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.

By Region: North America - 40%, Europe – 30%, APAC –20%, Latin America – 5%,Middle East & Africa–5%

Key players in the interventional cardiology devices market

Some of the prominent players operating in the interventional cardiology devices market include Boston Scientific Corporation (US), Medtronic (US), Abbott (US), B. Braun SE (Germany), Terumo Corporation (Japan), Edwards Lifesciences Corporation (US), Koninklijke Philips N.V. (Netherlands), Integer Holdings Corporation (US), Teleflex Incorporated (US), Penumbra, Inc. (US), Cook (US), Cordis (US), iVascular S.L.U (Spain), Biosensors International Group, Ltd (Singapore), BIOTRONIK SE & Co. KG (Germany), AMG International (Germany), ENDOCOR GmbH (Germany), InSitu Technologies, Inc. (US), Meril Life Sciences (India), Alvimedica (Istanbul), Cardionovum GmBH (Germany), Medinol Ltd (Turkey), Wellinq (Netherlands), Balton SP (Poland), Translumina (India).

Research Coverage:

The report analyzes the interventional cardiology devices market and aims at estimating the market size and future growth potential of this market based on various segments such as angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices and end user. The report also includes a product portfolio matrix of various interventional cardiology technologies available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall interventional cardiology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Of Analysis of key drivers (growing prevalence of cardiovascular diseases, technological advancements in interventional cardiology procedures, increased prevalence of diabetes & growing product launches by leading players in developing countries), restraints (availability of alternative treatments & recall of products by industry participants to limit the uptake of interventional cardiology equipment), opportunities (high growth potential in emerging markets & growing coronary stent demand in developing countries) and challenges (stringent regulatory requirements delaying the approval of cardiac devices).

Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global interventional cardiology devices market.

Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global interventional cardiology devices market

Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices and end user.

Market Diversification: Exhaustive information about new product and services or product and service enhancements, growing geographies, recent developments, and investments in the global interventional cardiology devices market.

Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global interventional cardiology devices market.

Tables List

Table 1 Inclusions & Exclusions

Table 2 Standard Currency Conversion Rates (Unit Of Usd)

Table 3 Interventional Cardiology Devices Market: Study Assumptions

Table 4 Risk Assessment Analysis: Interventional Cardiology Devices Market

Table 5 Global Annual Cardiac Surgical Volumes Per 100,000 Population (2023)

Table 6 Diabetic Population, By Region, 2019 Vs. 2030

Table 7 Key Companies Involved In Providing Drug-eluting Technologies

Table 8 Benefits Of Tavr Over Savr: Patient's Perspective

Table 9 Companies Providing Ffr Technologies

Table 10 Interventional Cardiology Devices Market: Porter’s Five Forces Analysis

Table 11 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 12 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 13 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations

Table 14 Latin America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 15 Middle East & Africa: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 16 Indicative Average Selling Price Of Key Players, By Type

Table 17 Indicative Average Selling Price Of Interventional Cardiology Devices, By Region, 2023

Table 18 Interventional Cardiology Devices Market: Role In Ecosystem

Table 19 List Of Patents/Patent Applications In The Interventional Cardiology Devices Market, 2021–2023

Table 20 Import Data For Interventional Cardiology Devices, By Country (2023)

Table 21 Export Data For Interventional Cardiology Devices, By Country (2023)

Table 22 Interventional Cardiology Devices Market: Detailed List Of Conferences & Events

Table 23 Influence Of Stakeholders On Buying Process For Top 3 End Users

Table 24 Key Buying Criteria For Top 3 End Users

Table 25 Interventional Cardiology Devices Market: Unmet Needs/End-user Expectations

Table 26 Interventional Cardiology Devices Market: Impact Of Gen Ai

Table 27 Interventional Cardiology Devices Market, By Product Type,

2022–2029 (Usd Million)

Table 28 Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 29 Angioplasty Stents Market, By Country, 2022–2029 (Usd Million)

Table 30 Drug-eluting Angioplasty Stents Market, By Country,

2022–2029 (Usd Million)

Table 31 Drug-eluting Angioplasty Stents Market, By Region,

2022–2029 (Thousand Units)

Table 32 Bare-metal Angioplasty Stents Market, By Country,

2022–2029 (Usd Million)

Table 33 Bare-metal Angioplasty Stents Market, By Region,

2022–2029 (Thousand Units)

Table 34 Bioabsorbable Angioplasty Stents Market, By Country,

2022–2029 (Usd Million)

Table 35 Structural Heart Devices Market, By Type, 2022–2029 (Usd Million)

Table 36 Structural Heart Devices Market, By Country, 2022–2029 (Usd Million)

Table 37 Aortic Valve Therapy Devices Market, By Country,

2022–2029 (Usd Million)

Table 38 Aortic Valve Therapy Devices Market, By Region,

2022–2029 (Thousand Units)

Table 39 Other Therapy Devices Market, By Country, 2022–2029 (Usd Million)

Table 40 Other Therapy Devices Market, By Region, 2022–2029 (Thousand Units)

Table 41 Catheters Market, By Type, 2022–2029 (Usd Million)

Table 42 Catheters Market, By Country, 2022–2029 (Usd Million)

Table 43 Angiography Catheters Market, By Country, 2022–2029 (Usd Million)

Table 44 Angiography Catheters Market, By Region, 2022–2029 (Thousand Units)

Table 45 Guiding Catheters Market, By Country, 2022–2029 (Usd Million)

Table 46 Guiding Catheters Market, By Region, 2022–2029 (Thousand Units)

Table 47 Ivus/Oct Catheters Market, By Country, 2022–2029 (Usd Million)

Table 48 Ivus/Oct Catheters Market, By Region, 2022–2029 (Thousand Units)

Table 49 Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 50 Angioplasty Balloons Market, By Country, 2022–2029 (Usd Million)

Table 51 Old/Normal Angioplasty Balloons Market, By Country,

2022–2029 (Usd Million)

Table 52 Drug-eluting Angioplasty Balloons Market, By Country,

2022–2029 (Usd Million)

Table 53 Drug-eluting Angioplasty Balloons Market, By Region,

2022–2029 (Thousand Units)

Table 54 Cutting/Scoring Angioplasty Balloons Market, By Country,

2022–2029 (Usd Million)

Table 55 Plaque Modification Devices Market, By Type, 2022–2029 (Usd Million)

Table 56 Plaque Modification Devices Market, By Country,

2022–2029 (Usd Million)

Table 57 Procedure Data For Plaque Modification Devices, By Region,

2023 (Million)

Table 58 Thrombectomy Devices Market, By Country, 2022–2029 (Usd Million)

Table 59 Atherectomy Devices Market, By Country, 2022–2029 (Usd Million)

Table 60 Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 61 Hemodynamic Flow Alteration Devices Market, By Country,

2022–2029 (Usd Million)

Table 62 Embolic Protection Devices Market, By Country,

2022–2029 (Usd Million)

Table 63 Chronic Total Occlusion Devices Market, By Country,

2022–2029 (Usd Million)

Table 64 Other Devices Market, By Type, 2022–2029 (Usd Million)

Table 65 Other Devices Market, By Country, 2022–2029 (Usd Million)

Table 66 Guidewires Market, By Country, 2022–2029 (Usd Million)

Table 67 Vascular Closure Devices Market, By Country, 2022–2029 (Usd Million)

Table 68 Introducer Sheaths Market, By Country, 2022–2029 (Usd Million)

Table 69 Balloon Inflation Devices Market, By Country, 2022–2029 (Usd Million)

Table 70 Hemostasis Heart Valves Market, By Country, 2022–2029 (Usd Million)

Table 71 Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 72 Interventional Cardiology Devices Market For Hospitals,

By Country, 2022–2029 (Usd Million)

Table 73 Interventional Cardiology Devices Market For Ambulatory Surgery Centers, By Country, 2022–2029 (Usd Million)

Table 74 Interventional Cardiology Devices Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 75 Interventional Cardiology Devices Market, By Region,

2022–2029 (Usd Million)

Table 76 North America: Interventional Cardiology Devices Market,

By Country, 2022–2029 (Usd Million)

Table 77 North America: Interventional Cardiology Devices Market,

By Product Type, 2022–2029 (Usd Million)

Table 78 North America: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 79 North America: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 80 North America: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 81 North America: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 82 North America: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 83 North America: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 84 North America: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 85 North America: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 86 Us: Macroeconomic Indicators

Table 87 Us: Interventional Cardiology Devices Market, By Product Type,

2022–2029 (Usd Million)

Table 88 Us: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 89 Us: Structural Heart Devices Market, By Type, 2022–2029 (Usd Million)

Table 90 Us: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 91 Us: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 92 Us: Plaque Modification Devices Market, By Type, 2022–2029 (Usd Million)

Table 93 Us: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 94 Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 95 Us: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 96 Canada: Macroeconomic Indicators

Table 97 Canada: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 98 Canada: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 99 Canada: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 100 Canada: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 101 Canada: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 102 Canada: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 103 Canada: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 104 Canada: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 105 Canada: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 106 Europe: Interventional Cardiology Devices Market, By Country,

2022–2029 (Usd Million)

Table 107 Europe: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 108 Europe: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 109 Europe: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 110 Europe: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 111 Europe: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 112 Europe: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 113 Europe: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 114 Europe: Other Interventional Cardiology Devices Market, By Type, 2022–2029 (Usd Million)

Table 115 Europe: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 116 Germany: Macroeconomic Indicators

Table 117 Germany: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 118 Germany: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 119 Germany: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 120 Germany: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 121 Germany: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 122 Germany: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 123 Germany: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 124 Germany: Other Interventional Cardiology Devices Market, By Type, 2022–2029 (Usd Million)

Table 125 Germany: Interventional Cardiology Devices Market, By End User, 2022–2029 (Usd Million)

Table 126 France: Macroeconomic Indicators

Table 127 France: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 128 France: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 129 France: Structural Heart Devices Market, By Type, 2022–2029 (Usd Million)

Table 130 France: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 131 France: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 132 France: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 133 France: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 134 France: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 135 France: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 136 Uk: Macroeconomic Indicators

Table 137 Uk: Interventional Cardiology Devices Market, By Product Type,

2022–2029 (Usd Million)

Table 138 Uk: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 139 Uk: Structural Heart Devices Market, By Type, 2022–2029 (Usd Million)

Table 140 Uk: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 141 Uk: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 142 Uk: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 143 Uk: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 144 Uk: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 145 Uk: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 146 Italy: Macroeconomic Indicators

Table 147 Italy: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 148 Italy: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 149 Italy: Structural Heart Devices Market, By Type, 2022–2029 (Usd Million)

Table 150 Italy: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 151 Italy: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 152 Italy: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 153 Italy: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 154 Italy: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 155 Italy: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 156 Spain: Macroeconomic Indicators

Table 157 Spain: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 158 Spain: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 159 Spain: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 160 Spain: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 161 Spain: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 162 Spain: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 163 Spain: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 164 Spain: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 165 Spain: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 166 Rest Of Europe: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 167 Rest Of Europe; Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 168 Rest Of Europe: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 169 Rest Of Europe: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 170 Rest Of Europe: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 171 Rest Of Europe: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 172 Rest Of Europe: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 173 Rest Of Europe: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 174 Rest Of Europe: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 175 Asia Pacific: Interventional Cardiology Devices Market, By Country, 2022–2029 (Usd Million)

Table 176 Asia Pacific: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 177 Asia Pacific: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 178 Asia Pacific: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 179 Asia Pacific: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 180 Asia Pacific: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 181 Asia Pacific: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 182 Asia Pacific: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 183 Asia Pacific: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 184 Asia Pacific: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 185 China: Macroeconomic Indicators

Table 186 China: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 187 China: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 188 China: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 189 China: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 190 China: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 191 China: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 192 China: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 193 China: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 194 China: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 195 Japan: Macroeconomic Indicators

Table 196 Japan: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 197 Japan: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 198 Japan: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 199 Japan Catheters Market, By Type, 2022–2029 (Usd Million)

Table 200 Japan: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 201 Japan: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 202 Japan: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 203 Japan: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 204 Japan: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 205 India: Macroeconomic Indicators

Table 206 India: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 207 India: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 208 India: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 209 India: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 210 India: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 211 India: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 212 India: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 213 India: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 214 India: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 215 Australia: Macroeconomic Indicators

Table 216 Australia: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 217 Australia: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 218 Australia: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 219 Australia: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 220 Australia: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 221 Australia: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 222 Australia: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 223 Australia: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 224 Australia: Interventional Cardiology Devices Market, By End User, 2022–2029 (Usd Million)

Table 225 South Korea: Macroeconomic Indicators

Table 226 South Korea: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 227 South Korea: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 228 South Korea: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 229 South Korea: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 230 South Korea: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 231 South Korea: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 232 South Korea: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 233 South Korea: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 234 South Korea: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 235 Rest Of Asia Pacific: Interventional Cardiology Devices Market,

By Product Type, 2022–2029 (Usd Million)

Table 236 Rest Of Asia Pacific: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 237 Rest Of Asia Pacific: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 238 Rest Of Asia Pacific: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 239 Rest Of Asia Pacific: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 240 Rest Of Asia Pacific: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 241 Rest Of Asia Pacific: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 242 Rest Of Asia Pacific: Other Interventional Cardiology Devices Market, By Type, 2022–2029 (Usd Million)

Table 243 Rest Of Asia Pacific: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 244 Latin America: Interventional Cardiology Devices Market, By Country, 2022–2029 (Usd Million)

Table 245 Latin America: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 246 Latin America: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 247 Latin America: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 248 Latin America: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 249 Latin America: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 250 Latin America: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 251 Latin America: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 252 Latin America: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 253 Latin America: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 254 Brazil: Macroeconomic Indicators

Table 255 Brazil: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 256 Brazil: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 257 Brazil: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 258 Brazil: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 259 Brazil: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 260 Brazil: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 261 Brazil: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 262 Brazil: Other Interventional Cardiology Devices Market, By Type,

2022–2029 (Usd Million)

Table 263 Brazil: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 264 Mexico: Macroeconomic Indicators

Table 265 Mexico: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 266 Mexico: Angioplasty Stents Market, By Type, 2022–2029 (Usd Million)

Table 267 Mexico: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 268 Mexico: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 269 Mexico: Angioplasty Balloons Market, By Type, 2022–2029 (Usd Million)

Table 270 Mexico: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 271 Mexico: Hemodynamic Flow Alteration Devices Market, By Type,

2022–2029 (Usd Million)

Table 272 Mexico: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 273 Mexico: Interventional Cardiology Devices Market, By End User,

2022–2029 (Usd Million)

Table 274 Rest Of Latin America: Interventional Cardiology Devices Market,

By Product Type, 2022–2029 (Usd Million)

Table 275 Rest Of Latin America: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 276 Rest Of Latin America: Structural Heart Devices Market,

By Type, 2022–2029 (Usd Million)

Table 277 Rest Of Latin America: Catheters Market, By Type,

2022–2029 (Usd Million)

Table 278 Rest Of Latin America: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 279 Rest Of Latin America: Plaque Modification Devices Market,

By Type, 2022–2029 (Usd Million)

Table 280 Rest Of Latin America: Hemodynamic Flow Alteration Devices Market, By Type, 2022–2029 (Usd Million)

Table 281 Rest Of Latin America: Other Interventional Cardiology Devices Market, By Type, 2022–2029 (Usd Million)

Table 282 Rest Of Latin America: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 283 Middle East & Africa: Interventional Cardiology Devices Market,

By Country, 2022–2029 (Usd Million)

Table 284 Middle East & Africa: Interventional Cardiology Devices Market,

By Product Type, 2022–2029 (Usd Million)

Table 285 Middle East & Africa: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 286 Middle East & Africa: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 287 Middle East & Africa: Catheters Market, By Type,

2022–2029 (Usd Million)

Table 288 Middle East & Africa: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 289 Middle East & Africa: Plaque Modification Devices Market, By Type, 2022–2029 (Usd Million)

Table 290 Middle East & Africa: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 291 Middle East & Africa: Other Interventional Cardiology Devices Market, By Type, 2022–2029 (Usd Million)

Table 292 Middle East & Africa: Interventional Cardiology Devices Market,

By End User, 2022–2029 (Usd Million)

Table 293 Gcc Countries: Interventional Cardiology Devices Market,

By Product Type, 2022–2029 (Usd Million)

Table 294 Gcc Countries: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 295 Gcc Countries: Structural Heart Devices Market, By Type,

2022–2029 (Usd Million)

Table 296 Gcc Countries: Catheters Market, By Type, 2022–2029 (Usd Million)

Table 297 Gcc Countries: Angioplasty Balloons Market, By Type,

2022–2029 (Usd Million)

Table 298 Gcc Countries: Plaque Modification Devices Market, By Type,

2022–2029 (Usd Million)

Table 299 Gcc Countries: Hemodynamic Flow Alteration Devices Market,

By Type, 2022–2029 (Usd Million)

Table 300 Gcc Countries: Other Interventional Cardiology Devices Market,

By Type, 2022–2029 (Usd Million)

Table 301 Gcc Countries: Interventional Cardiology Devices Market, By End User, 2022–2029 (Usd Million)

Table 302 Rest Of Middle East & Africa: Interventional Cardiology Devices Market, By Product Type, 2022–2029 (Usd Million)

Table 303 Rest Of Middle East & Africa: Angioplasty Stents Market, By Type,

2022–2029 (Usd Million)

Table 304 Rest Of Middle East & Africa: Structural Heart Devices Market,

By Type, 2022–2029 (Usd Million)

Table 305 Rest Of Middle East & Africa: Catheters Market, By Type,

2022–2029 (Usd Million)

Table 306 Rest Of Middle East & Africa: Angioplasty Balloons Market,

By Type, 2022–2029 (Usd Million)

Table 307 Rest Of Middle East & Africa: Plaque Modification Devices Market,

By Type, 2022–2029 (Usd Million)

Table 308 Rest Of Middle East & Africa: Hemodynamic Flow Alteration Devices Market, By Type, 2022–2029 (Usd Million)

Table 309 Rest Of Middle East & Africa: Other Interventional Cardiology Devices Market, By Type, 2022–2029 (Usd Million)

Table 310 Rest Of Middle East & Africa: Interventional Cardiology Devices Market, By End User, 2022–2029 (Usd Million)

Table 311 Overview Of Strategies Deployed By Key Manufacturing Companies

Table 312 Interventional Cardiology Devices Market: Degree Of Competition

Table 313 Region Footprint

Table 314 Interventional Cardiology Devices Market: Product Footprint

Table 315 Angioplasty Stents Footprint

Table 316 Structural Heart Devices Footprint

Table 317 Catheters Footprint

Table 318 Angioplasty Balloons Footprint

Table 319 Plaque Modification Devices Footprint

Table 320 Hemodynamic Flow Alteration Devices Footprint

Table 321 Other Interventional Cardiology Devices Footprint

Table 322 End-user Footprint

Table 323 Interventional Cardiology Devices Market: Detailed List Of Key Start-ups/Smes

Table 324 Interventional Cardiology Devices Market: Competitive Benchmarking Of Startups/Smes

Table 325 Interventional Cardiology Devices Market: Product Launches & Approvals, January 2021–october 2024

Table 326 Interventional Cardiology Devices Market: Deals, January 2021– October 2024

Table 327 Interventional Cardiology Devices Market: Expansions, January 2021–october 2024

Table 328 Boston Scientific Corporation: Company Overview

Table 329 Boston Scientific Corporation: Products Offered

Table 330 Boston Scientific Corporation: Product Launches & Approvals, January 2021–october 2024

Table 331 Boston Scientific Corporation: Deals, January 2021−october 2024

Table 332 Medtronic: Company Overview

Table 333 Medtronic: Products Offered

Table 334 Medtronic: Product Approvals, January 2021–october 2024

Table 335 Medtronic: Deals, January 2021–october 2024

Table 336 Abbott: Company Overview

Table 337 Abbott: Products Offered

Table 338 Abbott: Product Launches & Approvals, January 2021−october 2024

Table 339 Abbott: Deals, January 2021−october 2024

Table 340 Koninklijke Philips N.V.: Company Overview

Table 341 Koninklijke Philips N.V.: Products Offered

Table 342 Koninklijke Philips N.V.: Deals, January 2021−october 2024

Table 343 Terumo Corporation: Company Overvie w

Table 344 Terumo Corporation: Products Offered

Table 345 Terumo Corporation: Product Launches, January 2021–october 2024

Table 346 Terumo Corporation.: Expansions, January 2021−october 2024

Table 347 Edwards Lifesciences Corporation: Company Overview

Table 348 Edwards Lifesciences Corporation: Products Offered

Table 349 Edwards Lifesciences Corporation: Product Launches & Approvals, January 2021−october 2024

Table 350 Edwards Lifesciences Corporation: Deals, January 2021−october 2024

Table 351 B. Braun Se: Company Overview

Table 352 B. Braun Se: Products Offered

Table 353 B. Braun Se: Product Launches & Approvals, January 2021−

October 2024

Table 354 B. Braun Se: Deals, January 2021−october 2024

Table 355 Integer Holdings Corporation: Company Overview

Table 356 Integer Holdings Corporation: Products Offered

Table 357 Integer Holdings Corporation.: Deals, January 2021−october 2024

Table 358 Integer Holdings Corporation: Expansions, January 2021−

October 2024

Table 359 Teleflex Incorporated: Company Overview

Table 360 Teleflex Incorporated: Products Offered

Table 361 Teleflex Incorporated: Product Approvals, January 2021−

October 2024

Table 362 Penumbra, Inc.: Company Overview

Table 363 Penumbra, Inc: Products Offered

Table 364 Penumbra, Inc: Product Launches & Approvals, January 2021−

October 2024

Table 365 Cook: Company Overview

Table 366 Cook: Products Offered

Table 367 Cook: Deals, January 2021–october 2024

Table 368 Cordis: Company Overview

Table 369 Cordis.: Products Offered

Table 370 Cordis: Product Launches & Approvals, January 2021−october 2024

Table 371 Cordis: Deals, January 2021−october 2024

Table 372 Ivascular S.L.U.: Company Overview

Table 373 Ivascular S.L.U: Products Offered

Table 374 Biosensors International Group, Ltd.: Company Overview

Table 375 Biosensors International Group, Ltd.: Products Offered

Table 376 Biosensors International Group, Ltd: Product Launches, January 2021−october 2024

Table 377 Biotronik Se & Co. Kg: Company Overview

Table 378 Biotronik Se & Co. Kg: Products Offered

Table 379 Biotronik Se & Co. Kg: Product Launches, January 2021−october 2024

Figures List

Figure 1 Interventional Cardiology Devices Market Segmentation

Figure 2 Research Design

Figure 3 Primary Sources

Figure 4 Breakdown Of Primary Interviews: Supply-side And Other Participants

Figure 5 Breakdown Of Primary Interviews: By Company Type, Designation,

And Region

Figure 6 Breakdown Of Primary Interviews (Demand Side): By End User, Designation, And Region

Figure 7 Market Size Approach – Revenue Share Analysis

Figure 8 Revenue Share Analysis Illustration: Medtronic (2023)

Figure 9 Top-down Approach

Figure 10 Supply-side Analysis: Interventional Cardiology Devices Market (2023)

Figure 11 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges

Figure 12 Cagr Projections

Figure 13 Data Triangulation Methodology

Figure 14 Angioplasty Stents Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 15 Structural Heart Devices Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 16 Catheters Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 17 Angioplasty Balloons Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 18 Plaque Modification Devices Market, By Type,

2024 Vs. 2029 (Usd Million)

Figure 19 Hemodynamic Flow Alteration Devices Market, By Type,

2024 Vs. 2029 (Usd Million)

Figure 20 Other Devices Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 21 Interventional Cardiology Devices Market, By End User,

2024 Vs. 2029 (Usd Million)

Figure 22 Geographic Snapshot Of Interventional Cardiology Devices Market

Figure 23 Increasing Prevalence Of Cvd And Diabetes To Propel Market

Figure 24 Hospitals Accounted For Largest Market Share In China For 2023

Figure 25 China To Grow At Highest Cagr During Forecast Period

Figure 26 Asia Pacific Market To Grow At Highest Cagr During Forecast Period

Figure 27 Interventional Cardiology Devices Market: Drivers, Restraints, Opportunities, And Challenges

Figure 28 Interventional Cardiology Devices Market: Supply Chain Analysis

Figure 29 Interventional Cardiology Devices Market: Value Chain Analysis

Figure 30 Interventional Cardiology Devices Market: Porter’s Five Forces Analysis

Figure 31 Indicative Average Selling Price Trend Of Interventional Cardiology Devices, By Product Type, 2023

Figure 32 Interventional Cardiology Devices Market: Ecosystem Map

Figure 33 Patent Publication Trends (January 2013–october 2024)

Figure 34 Top Applicants & Owners (Companies/Institutions) For Interventional Cardiology Devices Patents (January 2013–october 2024)

Figure 35 Top Applicant Countries/Regions For Interventional Cardiology Devices Patents (January 2013–october 2024)

Figure 36 Influence Of Stakeholders On Buying Process For Top 3 End Users

Figure 37 Key Buying Criteria For Top 3 End Users

Figure 38 Trends/Disruptions Impacting Customers’ Businesses In Interventional Cardiology Devices Market

Figure 39 Interventional Cardiology Devices: Adjacent Markets

Figure 40 Investment/Venture Capital Scenario In Interventional Cardiology Devices Market, 2019–2024

Figure 41 Interventional Cardiology Devices Market: Geographic Snapshot (2023)

Figure 42 North America: Interventional Cardiology Devices Market Snapshot

Figure 43 Asia Pacific: Interventional Cardiology Devices Market Snapshot

Figure 44 Revenue Analysis Of Key Players In Interventional Cardiology Devices Market (2019−2023)

Figure 45 Market Share Analysis, By Key Player (2023)

Figure 46 Interventional Cardiology Devices Market: Company Evaluation Matrix (Key Players), 2023

Figure 47 Interventional Cardiology Devices Market: Company Footprint

Figure 48 Interventional Cardiology Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 49 Ev/Ebitda Of Key Vendors

Figure 50 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Key Vendors

Figure 51 Interventional Cardiology Devices Market: Brand/Product Comparative Analysis

Figure 52 R&D Assessment Of Key Players In Interventional Cardiology Devices Market, 2021–2023

Figure 53 Boston Scientific Corporation: Company Snapshot (2023)

Figure 54 Medtronic: Company Snapshot (2023)

Figure 55 Abbott: Company Snapshot (2023)

Figure 56 Koninklijke Philips N.V.: Company Snapshot (2023)

Figure 57 Terumo Corporation: Company Snapshot (2023)

Figure 58 Edwards Lifesciences Corporation: Company Snapshot (2023)

Figure 59 B. Braun Se: Company Snapshot (2023)

Figure 60 Integer Holdings Corporation: Company Snapshot (2023)

Figure 61 Teleflex Incorporated: Company Snapshot (2023)

Figure 62 Penumbra, Inc.: Company Snapshot (2023)